In this paper, a propensity score-integrated composite likelihood (PSCL) approach is developed for cases in which the control arm of a two-arm randomized controlled trial (RCT) (treated vs control) is augmented with patients from real-world data (RWD) containing both clinical outcomes and covariates at the patient-level. RWD patients who were treated with the same therapy as the control arm of the RCT are considered for the augmentation. The PSCL approach first estimates the propensity score for every patient as the probability of the patient being in the RCT rather than the RWD, and then stratifies all patients into strata based on the estimated propensity scores. Within each propensity score stratum, a composite likelihood function is specified and utilized to down-weight the information contributed by the RWD source. Estimates of the stratum-specific parameters are obtained by maximizing the composite likelihood function. These stratum-specific estimates are then combined to obtain an overall population-level estimate of the parameter of interest. The performance of the proposed approach is evaluated via a simulation study. A hypothetical two-arm RCT and a hypothetical RWD source are used to illustrate the implementation of the proposed approach.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2020.1730877DOI Listing

Publication Analysis

Top Keywords

composite likelihood
16
control arm
12
propensity score-integrated
8
score-integrated composite
8
randomized controlled
8
controlled trial
8
real-world data
8
pscl approach
8
propensity score
8
likelihood function
8

Similar Publications

Background: Cardiovascular risk factors and depressive symptoms have both been independently shown to be negatively associated with cognitive function. However, the nature of the influence of comorbid depressive symptoms and cardiovascular risk on cognitive function is unclear, and there have been inconsistent findings as to which cognitive domains may be most associated with this relationship.

Method: U.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

University of Florida, Department of Clinical and Health Psychology, Gainesville, FL, USA.

Background: The primary aim of the current analysis was to evaluate the cumulative effect of different social determinants of health (SDoH) factors on vascular burden, cognition, and physical functioning.

Method: We conducted a secondary data analysis of the MIDUS 2 cross-sectional study. Participants were ages 55 and above.

View Article and Find Full Text PDF

Background: Interventional trials in Alzheimer's Disease (AD) are increasingly targeting early disease stages. To optimize the likelihood of successful outcomes for these trials, there is an important need for tools capable of identifying individuals prone to exhibit clinical progression throughout the course of the trial. The Expanded Brief Assessment of Cognition (Expanded-BAC) and the Virtual Reality Functional Capacity Assessment Tool - Short List (VRFCAT-SLx) are two computerized tests assessing cognitive and functional abilities, respectively.

View Article and Find Full Text PDF

Background: Greater physical activity (PA) is associated with better cognitive and vascular health, but accurate assessment of PA is challenging. Self-report questionnaires of PA may be compared against objective measures from smartwatch sensors; the correspondence between measures may be influenced by a variety of factors such as cognition or age. The focus of this study was to identify baseline participant characteristics (vascular risk, cognition) that influence the association between self-reported PA and PA measured with a Garmin Vivosmart 4 smartwatch in a racially diverse sample of older adults.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Amsterdam Neuroscience, Neurodegeneration, Amsterdam, Noord-Holland, Netherlands.

Background: Sporadic bvFTD is often misdiagnosed as a primary psychiatric disorder (PPD) due to overlapping clinical features and lack of reliable biomarkers. The multi-centre study DIPPA-FTD aims to develop diagnostic- and prognostic-algorithms that can distinguish sporadic bvFTD from late-onset PPD. The aim of the retrospective DIPPA-FTD study was to identify the strongest clinical discriminators.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!